✦ LIBER ✦

Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: Relationship of response to previous treatment

✍ Scribed by Blackledge, G.R.P.; Latief, T.; Mould, J.J.; Spooner, D.; Morrison, M.

Book ID: 122055235
Publisher: Elsevier Science
Year: 1986
Weight: 368 KB
Volume: 22
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(86)90012-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Open comparative trial of formestane ver

Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen

✍ M. Freue; M. Kjaer; C. Boni; J. Joliver; F. Jänicke; H.B. Willemse; R.C. Coombes 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Outcome in patients with advanced breast

Outcome in patients with advanced breast cancer treated with anastrozole following loss of reponse to tamoxifen and megestrol acetate

✍ F. Mihaimeed; S.M. Kelleher; S. Parbhoo 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 157 KB

680 - Phase II study of taxotere monothe

680 - Phase II study of taxotere monotherapy in previously treated patients (pts) with advanced breast cancer (ABC)

✍ C.G. Alexopoulos; G. Rigatos; A. Efremidou; A. Papacharalambous; A. Alexopoulos; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 256 KB

569 Treatment of advanced breast cancer

569 Treatment of advanced breast cancer with medroxyprogesterone acetate: A randomized evaluation of the dose-response relationship at two-dose levels. A phase III trial

✍ C. Rose; H.T. Mouridsen; E. Engelsman; M. Nooi; R. Sylvester 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Responses to chemotherapy or chemohormon

Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy: A subset analysis of CALGB study 8081

✍ Carl G. Kardinal; Michael C. Perry; Ann H. Korzun; Mary Alice Rice; Sandra Ginsb 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 2 views

The Cancer and Leukemia Group B (CALGB) evaluated the response to subsequent chemotherapy or chemohormonal therapy in 46 patients with advanced breast cancer treated previously with adjuvant chemotherapy that had been completed 6 months or more before protocol entry. The results were compared with 3

Megestrol acetate (MGA) plus alpha 2A in

Megestrol acetate (MGA) plus alpha 2A interferon (IFN) as second line therapy in patients (pts) with advanced breast cancer (a.b.c.): Preliminary results of a multicentric phase II trial

✍ Amoroso, D.; Boccardo, F.; Miglietta, L.; Balestrero, M.; Brema, F.; Cellerino, 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 163 KB